Bipolar Disorder And Treatment Market Size And Share

  • Report Code : TIPRE00004576
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

双極性障害および治療市場シェア分析と機会2025-2031

Buy Now

Bipolar Disorder and Treatment Market Report Analysis

Bipolar Disorder and Treatment Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Astellas Pharma Inc
  • Allergan plc
  • GlaxoSmithKline plc
  • AbbVie Inc
  • Pfizer Inc
  • Johnson and Johnson

Regional Overview

  • 北米
  • ヨーロッパ
  • アジア太平洋
  • 南米および中米
  • 中東およびアフリカ

Market Segmentation

By タイプ
  • 双極性 I
  • 双極性 II
  • 気分循環症
By 薬剤の種類
  • 抗けいれん薬
  • 抗不安薬
  • 気分安定薬
  • 抗精神病薬
  • 抗うつ薬
By 作用機序
  • モノアミン酸化酵素阻害剤
  • セロトニン・ノルエピネフリン再取り込み阻害剤
  • 選択的セロトニン再取り込み阻害剤
  • ベータ遮断薬
  • 三環系抗うつ薬
  • ベンゾジアゼピン
By 治療[ECT
  • 電気けいれん療法
  • TMS